COA Certified · Every Batch Tested•Same-Day Shipping on Orders by 2PM EST•USA Sourced · USA Shipped•Free Shipping on Orders Over $300•4.9/5 from 2,400+ Verified Researchers•
COA Certified · Every Batch Tested•Same-Day Shipping on Orders by 2PM EST•USA Sourced · USA Shipped•Free Shipping on Orders Over $300•4.9/5 from 2,400+ Verified Researchers•
Quality Peptide USAQuality Peptide USA
HomeResearchCJC-1295 (No DAC) + Ipamorelin
Mechanism of Action

CJC-1295 (No DAC) + Ipamorelin Mechanism of Action: Receptor & Signaling Profile

3 min read•Published 2025-02-02•Quality Peptide USA Research

This co-lyophilized research blend pairs CJC-1295 without the Drug Affinity Complex (a 30-amino-acid GHRH analog) with Ipamorelin, a highly selective pentapeptide ghrelin-receptor agonist. The combination is used in growth hormone secretagogue research to study simultaneous activation of GHRH and GHS-R1a receptor pathways in pulsatile GH release models.. This guide covers mechanism of action for CJC-1295 (No DAC) + Ipamorelin — written for laboratory researchers sourcing US-synthesized peptides from Quality Peptide USA.

Primary Receptor Engagement

CJC-1295 (no DAC) binds the GHRH receptor on pituitary somatotrophs while Ipamorelin selectively activates GHS-R1a. The two pathways converge on cAMP-mediated GH release with synergistic amplitude in research models.

Downstream Signaling Cascades

Activation triggers second-messenger cascades that have been mapped in cell-line and primary-tissue models. Researchers studying CJC-1295 (No DAC) + Ipamorelin commonly track cAMP accumulation, MAPK phosphorylation, or PI3K/Akt activation as functional readouts. In synergistic ghrh + ghrelin pathway studies, these cascades correlate with the phenotypic endpoints most often reported in peer-reviewed studies.

Selectivity and Off-Target Profile

Selectivity is one of the most important variables when designing experiments around CJC-1295 (No DAC) + Ipamorelin. Off-target activity at related receptor families is generally minimal in standard binding panels, but investigators using high-concentration protocols should validate selectivity in their specific cell line. For research comparing CJC-1295 (No DAC) + Ipamorelin to structurally adjacent peptides, side-by-side dose-response curves remain the gold standard.

Why Mechanism Drives Sourcing

Subtle sequence impurities can mask or amplify mechanism-driven readouts. That is why every batch of CJC-1295 (No DAC) + Ipamorelin sold by Quality Peptide USA is verified by HPLC-MS for sequence integrity, with mass spectrometry traces included in the published certificate of analysis. US-synthesized peptides give research teams confidence that observed mechanism effects reflect the molecule — not a contaminant.

Research Use Only

All content is for laboratory and in-vitro research contexts only. Not intended to diagnose, treat, or prevent any condition. Not for human or veterinary consumption.

CJC-1295 (No DAC) + IpamorelinCJC-1295 (No DAC) + Ipamorelin researchCJC-1295 (No DAC) + Ipamorelin mechanism of actionCJC-1295 (No DAC) + Ipamorelin for salebuy CJC-1295 (No DAC) + IpamorelinCJC-1295 (No DAC) + Ipamorelin US synthesizedCJC-1295 (No DAC) + Ipamorelin American peptidesCJC-1295 (No DAC) + Ipamorelin certificate of analysisresearch peptidesQuality Peptide USA